News
-
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
October 10, 2024 -
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
September 27, 2024 -
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
September 13, 2024 -
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
September 12, 2024 -
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
September 10, 2024 -
Aclarion Added to PRISM Emerging Medical Devices Index
September 6, 2024 -
Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market
September 5, 2024 -
Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
August 29, 2024 -
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans
August 21, 2024 -
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
August 15, 2024